Drug Topics April 12, 2024
Killian Meara

After a long hiatus, research in psychedelic medicine is progressing rapidly. With the potential approval of MDMA in the near future, what role will pharmacists play in integrating these new therapies into treatment plans?

The use of psychedelic substances in ritual healing experiences reaches far back into human history. Ancient cultures from all over the world used different psychoactive compounds as a means of therapy: The ancient Greeks drank a concoction that contained a fungus with lysergic acid diethylamide (LSD)–like alkaloids to facilitate seasonal religious rites; members of a pre-Incan civilization in Bolivia took psilocybin, the active ingredient found in magic mushrooms; and Native Americans used mescaline from the peyote cactus in ritualistic prayer ceremonies.1

The use of these psychoactive...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mental Health, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Chasing the alchemy of trial diversity with a mix of culture change and practical mechanics
Paul Kelly on PBM Reform as a Means to an End: A 'Pay For' for Telehealth Flexibilities
Prescription delivery via drone is coming to more cities
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Podcast: Litigation Lawyer on PBMs and Defending Independent Pharmacies

Share This Article